Simulations Plus

Simulations Plus FCF Margin

The Free Cash Flow Margin of Simulations Plus (SLP) as of Sep 27, 2026 is 21.99 %. In the previous year, Free Cash Flow Margin was 18.22 % — a change of 20.72% (higher).

FCF Margin

21.99 %

YoY

20.72%

Last updated:

Free Cash Flow Margin of Simulations Plus is 2026 21.99 % . Free Cash Flow Margin of Simulations Plus was 2025 18.22 % . It decreases by 20.72% higher compared to the previous year.

The Simulations Plus FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
23.46 USD
Jan 1, 2019
28.50 USD
Jan 1, 2020
20.02 USD
Jan 1, 2021
31.48 USD
Jan 1, 2022
25.84 USD
Jan 1, 2023
29.51 USD
Jan 1, 2024
18.22 USD
Jan 1, 2025
21.99 USD
The Simulations Plus FCF Margin history
YEARFCF MarginYoY
21.99 %+20.72%
18.22 %-38.28%
29.51 %+14.21%
25.84 %-17.91%
31.48 %+57.21%
20.02 %-29.75%
28.50 %+21.52%
23.46 %+6.46%
22.03 %+5.26%
20.93 %-34.97%
32.19 %+161.14%
12.33 %—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Free Cash Flow Margin of Simulations Plus is 21.99 % in 2026.

Free Cash Flow Margin of Simulations Plus changed from 18.22 % to 21.99 %, representing a 20.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Simulations Plus with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Simulations Plus

All Key Metrics — Simulations Plus